Artiva Biotherapeutics, Inc. (ARTV)

NASDAQ: ARTV · Real-Time Price · USD

5.46

-0.01 (-0.18%)

Mar 4, 2026, 4:00 PM EST - Market closed

Artiva Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	25.51	40.24	53.5	102.53	160.92	25.44
Short-Term Investments	97.46	145.19	23.47	-	-	-
Cash & Short-Term Investments	122.97	185.43	76.97	102.53	160.92	25.44
Cash Growth	-16.14%	140.91%	-24.93%	-36.29%	532.51%	-
Total Current Assets	122.97	185.43	76.97	102.53	160.92	25.44
Total Assets	122.97	185.43	76.97	102.53	160.92	25.44
Net Cash (Debt)	122.97	185.43	76.97	102.53	160.92	25.44
Net Cash Growth	-33.68%	140.91%	-24.93%	-36.29%	532.51%	-
Net Cash Per Share	5.04	16.47	95.89	133.73	0.23	0.04

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q